AR116428A1 - Compuestos de 6-fluoro-2-metilbenzo[d]tiazol-5-ilo - Google Patents
Compuestos de 6-fluoro-2-metilbenzo[d]tiazol-5-iloInfo
- Publication number
- AR116428A1 AR116428A1 ARP190102645A ARP190102645A AR116428A1 AR 116428 A1 AR116428 A1 AR 116428A1 AR P190102645 A ARP190102645 A AR P190102645A AR P190102645 A ARP190102645 A AR P190102645A AR 116428 A1 AR116428 A1 AR 116428A1
- Authority
- AR
- Argentina
- Prior art keywords
- methylbenzo
- ilo
- thiazol
- fluoro
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Reivindicación 1: Un compuesto de la fórmula (1) en donde R es hidrógeno o metilo; y Z es: un compuesto del grupo de fórmulas (2), o una sal aceptable desde el punto de vista farmacéutico de este.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862736588P | 2018-09-26 | 2018-09-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR116428A1 true AR116428A1 (es) | 2021-05-05 |
Family
ID=68085016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190102645A AR116428A1 (es) | 2018-09-26 | 2019-09-18 | Compuestos de 6-fluoro-2-metilbenzo[d]tiazol-5-ilo |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10752632B2 (es) |
| EP (1) | EP3856739A1 (es) |
| JP (2) | JP7081047B2 (es) |
| CN (1) | CN112955446A (es) |
| AR (1) | AR116428A1 (es) |
| CA (1) | CA3113968C (es) |
| TW (1) | TWI716107B (es) |
| WO (1) | WO2020068530A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4126858A1 (en) * | 2020-03-26 | 2023-02-08 | Richter Gedeon Nyrt. | Dihydro-2-pyrrolo[3,4-c]pyridine derivatives as gabaa a5 receptor modulators |
| WO2024081775A1 (en) | 2022-10-14 | 2024-04-18 | Eli Lilly And Company | Synthesis of 6-fluoro-2-methylbenzo[d]thiazol-5-yl compounds |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8726763D0 (en) | 1987-11-16 | 1987-12-23 | Fujisawa Pharmaceutical Co | Thiazole compounds |
| TW504510B (en) * | 1996-05-10 | 2002-10-01 | Janssen Pharmaceutica Nv | 2,4-diaminopyrimidine derivatives |
| SE0302116D0 (sv) | 2003-07-21 | 2003-07-21 | Astrazeneca Ab | Novel compounds |
| US9120781B2 (en) | 2010-05-11 | 2015-09-01 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| AU2014241065B2 (en) | 2013-03-14 | 2017-08-31 | Merck Patent Gmbh | Glycosidase inhibitors |
| BR112017003658B1 (pt) | 2014-08-28 | 2022-12-06 | Asceneuron Sa | Composto, mistura, método para inibição de uma glicosidase, e, composição farmacêutica |
| WO2017071636A1 (zh) | 2015-10-30 | 2017-05-04 | 四川科伦博泰生物医药股份有限公司 | 酞嗪酮衍生物、其制备方法及用途 |
| WO2017106254A1 (en) | 2015-12-18 | 2017-06-22 | Merck Sharp & Dohme Corp. | Glycosidase inhibitors and uses thereof |
| FR3046053B1 (fr) | 2015-12-24 | 2017-12-22 | Sagem Defense Securite | Module de pied pour une structure d'exosquelette |
| MA43677A (fr) * | 2016-02-25 | 2018-11-28 | Asceneuron Sa | Inhibiteurs de glycosidases |
| US20200079766A1 (en) | 2016-12-16 | 2020-03-12 | Janssen Pharmaceutica Nv | Monocyclic oga inhibitor compounds |
| CA3044762A1 (en) * | 2016-12-16 | 2018-06-21 | Janssen Pharmaceutica Nv | Bicyclic oga inhibitor compounds |
| AR110747A1 (es) | 2017-01-27 | 2019-05-02 | Lilly Co Eli | Compuestos de 5-metil-1,2,4-oxadiazol-3-ilo |
| TWI669302B (zh) | 2017-05-25 | 2019-08-21 | 美商美國禮來大藥廠 | 5-甲基-1,3,4-<img align="absmiddle" height="18px" width="27px" file="d10999.TIF" alt="其他非圖式 ed10999.png" img-content="tif" orientation="portrait" inline="yes" giffile="ed10999.png"></img>二唑-2-基化合物 |
-
2019
- 2019-09-17 TW TW108133388A patent/TWI716107B/zh active
- 2019-09-18 AR ARP190102645A patent/AR116428A1/es unknown
- 2019-09-19 CA CA3113968A patent/CA3113968C/en active Active
- 2019-09-19 EP EP19779722.8A patent/EP3856739A1/en active Pending
- 2019-09-19 WO PCT/US2019/051820 patent/WO2020068530A1/en unknown
- 2019-09-19 US US16/576,080 patent/US10752632B2/en active Active
- 2019-09-19 JP JP2021516782A patent/JP7081047B2/ja active Active
- 2019-09-19 CN CN201980062923.0A patent/CN112955446A/zh active Pending
-
2020
- 2020-07-28 US US16/940,504 patent/US10836773B1/en active Active
-
2022
- 2022-05-25 JP JP2022085223A patent/JP2022116171A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020068530A1 (en) | 2020-04-02 |
| US10752632B2 (en) | 2020-08-25 |
| JP7081047B2 (ja) | 2022-06-06 |
| US10836773B1 (en) | 2020-11-17 |
| US20200354370A1 (en) | 2020-11-12 |
| CA3113968C (en) | 2023-08-01 |
| EP3856739A1 (en) | 2021-08-04 |
| TWI716107B (zh) | 2021-01-11 |
| TW202026293A (zh) | 2020-07-16 |
| US20200095254A1 (en) | 2020-03-26 |
| CA3113968A1 (en) | 2020-04-02 |
| JP2022502389A (ja) | 2022-01-11 |
| JP2022116171A (ja) | 2022-08-09 |
| CN112955446A (zh) | 2021-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY38297A (es) | Compuestos derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-diona, composiciones, métodos y usos de los mismos | |
| MX2021000795A (es) | Compuestos heterociclicos para inhibir la actividad de shp2. | |
| AR114803A1 (es) | Compuestos de 4-aminoisoindolin-1,3-diona sustituida, composiciones de estos y métodos de tratamiento con dichos compuestos | |
| AR115949A1 (es) | Compuestos heterocíclicos | |
| AR109349A1 (es) | Compuestos y usos | |
| AR108711A1 (es) | Compuestos moduladores de fxr (nr1h4) | |
| MX2020009530A (es) | Inhibidores de la o-glicoproteína-2-acetamido-2-desoxi-3-dglicopir anosidasa. | |
| MX371167B (es) | Inhibidores de inhibidores del factor beta de crecimiento de transformacion (tgf-beta). | |
| AR107864A1 (es) | ÁCIDO 7a,11b-DIHIDROXI-6a-ETIL-5b-COLAN-24-OICO Y COMPOSICIONES FARMACÉUTICAS | |
| CO2022008968A2 (es) | Nuevos derivados de metilquinazolinona | |
| AR119672A1 (es) | Inhibidor de 15-pgdh | |
| AR116283A1 (es) | Inhibidores del sarcómero cardíaco | |
| AR111806A1 (es) | Derivados de indol n-sustituidos | |
| EA202193015A1 (ru) | Ингибиторы cdk | |
| AR121226A1 (es) | Compuestos y usos de estos | |
| MX2020000576A (es) | Compuestos quimicos. | |
| PH12020550168A1 (en) | Griseofulvin compound and pharmaceutical use thereof | |
| AR117920A1 (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana | |
| CO2023015419A2 (es) | Compuesto de péptido corto de prolina modificado con anillo y uso del mismo | |
| AR116428A1 (es) | Compuestos de 6-fluoro-2-metilbenzo[d]tiazol-5-ilo | |
| PH12020552186A1 (en) | Cyanotriazole compounds and uses thereof | |
| CL2022000893A1 (es) | Derivados de 2-azaspiro[3,4]octano como agonistas de m4 | |
| ECSP22027784A (es) | Derivados de 2azaespiro[3.4]octano como agonistas de m4 | |
| AR110770A1 (es) | Moduladores del canal de potasio | |
| AR118141A1 (es) | Compuestos para el tratamiento, alivio o prevención de trastornos asociados con los agregados de tau |